61 related articles for article (PubMed ID: 3073572)
1. [Long-term treatment of hypertension with a selective beta l-blocker without sympathomimetic activity. I. Antihypertensive and hemodynamic effects].
Sirakova V; Penkov N; Kaponov Kh
Vutr Boles; 1988; 27(6):21-5. PubMed ID: 3073572
[TBL] [Abstract][Full Text] [Related]
2. [Systolic pressure--left-ventricular telesystolic volume ratio in the treatment of hypertension with a cardioselective beta-blockader without inner sympathomimetic activity].
Sirakova V
Vutr Boles; 1988; 27(3):47-50. PubMed ID: 3206902
[TBL] [Abstract][Full Text] [Related]
3. [Long-term treatment of hypertension with a selective beta-1-blockader without sympathomimetic activity. II. Changes in the structure and function of the left ventricle].
Sirakova V; Penkov N; Kaponov Kh
Vutr Boles; 1989; 28(1):31-6. PubMed ID: 2525846
[TBL] [Abstract][Full Text] [Related]
4. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
Lyngstam O; Rydén L
Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol.
Corea L; Bentivoglio M; Verdecchia P; Provvidenza M; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):365-70. PubMed ID: 6236155
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of the beta-blocker chlorpropanol (tobanum) in hypertension patients].
Sirakova V; Penkov N; Kaponov Kh
Vutr Boles; 1986; 25(1):35-41. PubMed ID: 2872751
[TBL] [Abstract][Full Text] [Related]
7. The role of the new beta-blockers in treating cardiovascular disease.
Weber MA
Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of guanfacine in essential hypertension.
Feldstein CA; Cohen AA; Sabaris RP; Burucúa JE
Clin Ther; 1984; 6(3):325-34. PubMed ID: 6373009
[TBL] [Abstract][Full Text] [Related]
9. The long-term antihypertensive efficacy and safety of a new felodipine-metoprolol combination tablet. The Swedish/UK and German Study Groups.
Hosie J; Dahlöf B; Klein G
Blood Press Suppl; 1993; 1():46-50. PubMed ID: 8173690
[TBL] [Abstract][Full Text] [Related]
10. Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease.
Stewart RA; Raffel OC; Kerr AJ; Gabriel R; Zeng I; Young AA; Cowan BR
Circulation; 2008 Sep; 118(10):1041-6. PubMed ID: 18725484
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
Zineh I; Beitelshees AL; Gaedigk A; Walker JR; Pauly DF; Eberst K; Leeder JS; Phillips MS; Gelfand CA; Johnson JA
Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
[TBL] [Abstract][Full Text] [Related]
12. Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertension.
Beitelshees AL; Zineh I; Yarandi HN; Pauly DF; Johnson JA
Pharmacotherapy; 2006 Sep; 26(9):1247-54. PubMed ID: 16945046
[TBL] [Abstract][Full Text] [Related]
13. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
Zanchetti A
Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
Ibrahim MM; el-Boghdadly B; Zaghloul SS
J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
[TBL] [Abstract][Full Text] [Related]
15. [Ambulatory treatment of hypertension with the beta-blockader corgard (nadolol)].
Charyev KhE; Erina EV; Iurenev AP; Lediasheva GA
Ter Arkh; 1984; 56(11):43-6. PubMed ID: 6523386
[TBL] [Abstract][Full Text] [Related]
16. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
O'Connor DT; Mosley CA; Cervenka J; Bernstein KN
J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882
[TBL] [Abstract][Full Text] [Related]
17. A systemic hemodynamic evaluation of indapamide.
Gensini G; Esente P; Giambartolomei A
Clin Ther; 1983; 5(5):475-82. PubMed ID: 6616523
[TBL] [Abstract][Full Text] [Related]
18. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
Papademetriou V; Hainer JW; Sugg J; Munzer D;
Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
[TBL] [Abstract][Full Text] [Related]
19. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive effect and tolerability of two fixed combination of metoprolol and hydrochlorothiazide followed by a long-term tolerance study with one combination.
Liedholm H; Ursing D
Ann Clin Res; 1981; 13 Suppl 30():45-53. PubMed ID: 7027893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
